Unresolved Complexity in the Gene Regulatory Network Underlying EMT

被引:33
作者
Lavin, Deborah P. [1 ]
Tiwari, Vijay K. [1 ]
机构
[1] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland
关键词
EMT; cancer; gene regulation; epigenetics; signaling; transcription factors; chromatin; EPITHELIAL-MESENCHYMAL-TRANSITION; BREAST-CANCER CELLS; ASSEMBLY FACTOR-I; NF-KAPPA-B; LUNG-CANCER; DOWN-REGULATION; UP-REGULATION; E-CADHERIN; TRANSCRIPTION FACTORS; CHROMATIN REMODELERS;
D O I
10.3389/fonc.2020.00554
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial to mesenchymal transition (EMT) is the process whereby a polarized epithelial cell ceases to maintain cell-cell contacts, loses expression of characteristic epithelial cell markers, and acquires mesenchymal cell markers and properties such as motility, contractile ability, and invasiveness. A complex process that occurs during development and many disease states, EMT involves a plethora of transcription factors (TFs) and signaling pathways. Whilst great advances have been made in both our understanding of the progressive cell-fate changes during EMT and the gene regulatory networks that drive this process, there are still gaps in our knowledge. Epigenetic modifications are dynamic, chromatin modifying enzymes are vast and varied, transcription factors are pleiotropic, and signaling pathways are multifaceted and rarely act alone. Therefore, it is of great importance that we decipher and understand each intricate step of the process and how these players at different levels crosstalk with each other to successfully orchestrate EMT. A delicate balance and fine-tuned cooperation of gene regulatory mechanisms is required for EMT to occur successfully, and until we resolve the unknowns in this network, we cannot hope to develop effective therapies against diseases that involve aberrant EMT such as cancer. In this review, we focus on data that challenge these unknown entities underlying EMT, starting with EMT stimuli followed by intracellular signaling through to epigenetic mechanisms and chromatin remodeling.
引用
收藏
页数:19
相关论文
共 206 条
[1]  
[Anonymous], 2014, NEURAL CREST CELLS
[2]   Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness [J].
Anthony, K. -C. ;
Kaur, Jatinder ;
Kak, Ipshita ;
Assi, Jasmeet ;
MacMillan, Christina ;
Ralhan, Ranju ;
Walfish, Paul G. .
PLOS ONE, 2012, 7 (07)
[3]   Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer [J].
Awasthi, Niranjan ;
Mikels-Vigdal, Amanda J. ;
Stefanutti, Erin ;
Schwarz, Margaret A. ;
Monahan, Sheena ;
Smith, Victoria ;
Schwarz, Roderich E. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) :3878-3887
[4]  
Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575
[5]   Integrated use of bioinformatic resources reveals that co-targeting of histone deacetylases, IKBK and SRC inhibits epithelial-mesenchymal transition in cancer [J].
Barneh, Farnaz ;
Mirzaie, Mehdi ;
Nickchi, Payman ;
Tan, Tuan Zea ;
Thiery, Jean Paul ;
Piran, Mehran ;
Salimi, Mona ;
Goshadrou, Fatemeh ;
Aref, Amir R. ;
Jafari, Mohieddin .
BRIEFINGS IN BIOINFORMATICS, 2019, 20 (02) :717-731
[6]   Differential expression of SUMO-specific protease 7 variants regulates epithelial-mesenchymal transition [J].
Bawa-Khalfe, Tasneem ;
Lu, Long-Sheng ;
Zuo, Yong ;
Huang, Chao ;
Dere, Ruhee ;
Lin, Feng-Ming ;
Yeh, Edward T. H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (43) :17466-17471
[7]   SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms [J].
Bedi, U. ;
Scheel, A. H. ;
Hennion, M. ;
Begus-Nahrmann, Y. ;
Rueschoff, J. ;
Johnsen, S. A. .
ONCOGENE, 2015, 34 (04) :465-473
[8]   Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer [J].
Bedi, Upasana ;
Mishra, Vivek Kumar ;
Wasilewski, David ;
Scheel, Christina ;
Johnsen, Steven A. .
ONCOTARGET, 2014, 5 (08) :2016-2029
[9]   Determinants and dynamics of genome accessibility [J].
Bell, Oliver ;
Tiwari, Vijay K. ;
Thomae, Nicolas H. ;
Schuebeler, Dirk .
NATURE REVIEWS GENETICS, 2011, 12 (08) :554-564
[10]   Epigenetic IVD Tests for Personalized Precision Medicine in Cancer [J].
Beltran-Garcia, Jesus ;
Osca-Verdegal, Rebeca ;
Mena-Molla, Salvador ;
Garcia-Gimenez, Jose Luis .
FRONTIERS IN GENETICS, 2019, 10